UBS lowered the firm’s price target on Moderna (MRNA) to $108 from $140 and keeps a Buy rating on the shares following a model review.

UBS analyst Justin Forsythe maintained a Sell rating on Worldline (0QVI – Research Report) today and set a price target of €5.25. The ...

When the United States hiked tariffs on most goods entering the country almost a century ago, the consequences were severe: global trade plummeted and US exports collapsed, as other countries ...

Inflation, high interest rates and political instability made the wealthiest clients become more cautious with art purchases ...

SBI Life reported a 39% YoY growth in consolidated net profit, reaching Rs 529 crore in Q2 FY25. Net premium income rose 1% ...

Chainlink, the decentralized oracle network built on Ethereum, has introduced new privacy-preserving technologies ...

The first panel Tuesday at American Banker's Most Powerful Women in Banking Conference focused on banks' use of AI tools.

Let’s dig into how large the upcoming dividends could be. The post Here's the dividend forecast for Rio Tinto shares through ...

Now finally published in the UK, Barbara Kingsolver’s Holding the Line looks at the 1983 Phelps Dodge strike through the women’s eyes ...

Five UBS Wealth Management USA financial advisers based in the firm’s Pacific Desert Market have been named to the Forbes Top ...

JPMorgan Chase, Capital One and Royal Bank of Canada have been named the top AI leaders in banking in Evident's AI Index for ...

Burish attributes much of his group’s success to its stability – Maas may be the only team member who’s been there since he ...